The Health IDEA
|
The Health IDEA
Your Best Source for the Latest Health and Wellness Info for Better Living!
|
There is No One-Size-Fits-All Breast Cancer
Breast cancer. It is a simple phrase representing a complex journey thousands of women travel each year. Even during October, when Breast Cancer Awareness Month brings attention to the disease, many people don’t realize breast cancer is not just one disease; it’s extremely complex and classified into different types. To change the perception that breast cancer is just one disease, consider these tips.There is No One-Size-Fits-All Breast Cancer
(Family Features) Breast cancer. It is a simple phrase representing a complex journey thousands of women travel each year. Even during October, when Breast Cancer Awareness Month brings attention to the disease, many people don’t realize breast cancer is not just one disease; it’s extremely complex and classified into different types. Understanding the many types of breast cancer is important – not just for the 1-in-8 women who will be diagnosed in their lifetime, – but for those who love them, too.¹ Laura Ross knows first-hand. She was diagnosed with triple-negative, stage I breast cancer when she was 41 years old. 
“No one in my family had breast cancer and I had no information,” Ross said. “I had not even heard breast cancer had different types until the results came back from my biopsy.” Unprepared and in shock, she relied heavily on her support circle, which in addition to her doctor and healthcare team, helped her learn more about her diagnosis. Empowered by this information, Ross had the confidence to make informed treatment decisions with her doctor. You or someone you love may be affected by breast cancer in your lifetime and have to help make a treatment decision. To change the perception that breast cancer is just one disease, Living Beyond Breast Cancer, Genentech and ThirdLove created the “Not One Type” campaign, which offers these tips:
During October – and year-round – arm yourself with knowledge about the different types of the disease and use that information to be a more empowered patient or caregiver. Visit NotOneType.org to learn more. Photo courtesy of Getty Images ¹ American Cancer Society. Cancer Facts & Figures 2018. Atlanta: American Cancer Society; 2018. ² Kohler BA, et al. Annual Report to the Nation on the Status of Cancer, 1975–2011, Featuring Incidence of Breast Cancer Subtypes by Race/Ethnicity, Poverty, and State. J Natl Cancer Inst 2015;107(6):djv048. SOURCE:Genentech KEYWORDS
 (BPT) - Each year, more people die of lung cancer than any other form of cancer — more than colon, breast and prostate cancers combined. The American Cancer Society estimates of the 224,000 new cases of lung cancer diagnosed each year, 155,000 will succumb to the disease. Many have heard the statistics about lung cancer, but for those who have lived through it, or who have a friend or loved one battling the disease, these numbers are even more personal and frightening. The low five-year survival rate (five to 14 percent) for late-stage lung cancer patients makes the search for a way to treat this deadly disease all the more urgent. Genetic breakthroughs To beat cancer, early detection is critical. Scientific research over the past several decades has revealed that cancer is a disease primarily caused by changes — or mutations — in the genes. This discovery has led to a major shift in how early cancer can be detected and treated. Now, researchers are able to identify mutations in the genetic code that are most likely to cause potentially deadly cancers. This has led to the development of new testing technology and drugs that target those specific mutations. This approach is in stark contrast to traditional detection methods that are limited in their ability to test for a small number of specific mutations linked to only one possible treatment. This painstakingly long process can take several weeks to identify an effective treatment. In a matter of days, modern techniques using next-generation sequencing technology can save valuable time by avoiding the need to run multiple tests by simultaneously screening tumor samples for multiple mutations and multiple potential therapies. The new technology also reduces the likelihood of subjecting patients to unnecessary and invasive secondary biopsy procedures. New advancements in early detection and treatment The U.S. Food and Drug Administration (FDA) recently approved the Oncomine(TM) Dx Target Test, a first-of-its-kind genetic screening solution that can detect multiple gene mutations associated with non-small cell lung cancer (NSCLC) from a single tissue sample. The test has also been approved to aid in selecting which specific FDA-approved NSCLC treatment the patient may be eligible for. Take action and talk to your doctor A recent survey by the Journal of Precision Medicine showed that only about a third of patients and caregivers had a good understanding of genomic tools for cancer detection. That’s why talking to a doctor, loved ones and others about new techniques like sequencing-based tests to help inform more effective treatment options is important. Doctors and healthcare networks have a responsibility to their patients to provide the most effective innovations so patients receive the best care possible. KEYWORDS:
 (BPT) - Pancreatic cancer is one of the most deadly cancers, with a mere 29 percent one-year survival rate. In 2016, pancreatic cancer became the third leading cause of cancer death in the United States, surpassing breast cancer. The time frame between diagnosis and death is often short. Only 7 percent of people diagnosed with pancreatic cancer survive five years. This is incredibly small compared to prostate cancer or breast cancer, where more than 90 percent of patients survive for five years after diagnosis. "Most people are unaware of how deadly pancreatic cancer is," says Jim Rolfe, president of Rolfe Pancreatic Cancer Foundation. "These chilling statistics can serve as an eye-opener that motivates people to learn more about their risks and contact their health care professional." Early detection is important Although pancreatic cancer is one of the most deadly cancers, early detection can significantly impact survival rates. The five-year survival rate for pancreatic cancer approaches 25 percent if cancers are surgically removed while they are still small and have not spread to the lymph nodes. Know your family, know your risk Family history is a risk factor for pancreatic cancer. When you know more about your genetics and which members of your family have been affected by pancreatic cancer, you can better manage your own health. To make the process easier, the Rolfe Pancreatic Cancer Foundation has introduced a new series of online tools. Visit www.KnowMyRisk.org to download a worksheet and access other helpful tools that let you explore your family history and become your own health advocate. Print out the worksheet and call or visit your grandparents, parents and other extended family members. You may not be aware that someone a few generations removed from you was affected by cancer. Having this conversation can be empowering, because once you know your risks you can take charge of your future. Consider genetic counseling When considering how personal a cancer or disease diagnosis can be, it is no surprise that medicine is looking at our DNA to uncover information. This makes genetic counselors an important part of the health care team, helping you ask the right questions and uncover familial genetic risk factors. If you learn you have a history of pancreatic cancer in multiple family members, you should consider meeting with a genetic counselor to assess your level of risk. From there, the counselor and your doctor can decide on a course of action. To learn more about genetic counseling and find a local certified genetic counselor at the National Society of Genetic Counselors' database, visit www.KnowMyRisk.org. Take charge and be empowered "Don't take a backseat when it comes to your health," says Rolfe. "The first step toward early detection of pancreatic cancer is understanding your family history. From there, you can make informed decisions that help you live a full, healthy life." KEYWORDS
|
Archives
February 2019
Interested in Publishing on The Health IDEA?Send your query to the Publisher today! Categories
All
|
RSS Feed